Individualized Treatment of Hyperphosphatemia in Maintenance Hemodialysis Patients
NCT03861247
Hyperphosphatemia, Maintenance Hemodialysis
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT Number: NCT05699447
The goal of this retrospective observational cohort study is to analysis the 1-year mortality in older patients undergoing maintenance hemodialysis. The main question it aims to answer is to explore the risk factors affecting the mortality of older patients undergoing maintenance hemodialysis and establish a risk prediction score.
Data of older patients (age ≥65 years old) undergoing maintenance hemodialysis were collected from 2012-1-December 31, 2014, with data from Beijing Blood Purification Quality Control and Improvement Center (BJHDQCIC). Logistic regression model was used to evaluate the 1-year mortality and the influence of predictive factors. Internal validation of the model was performed using the bootstrap 1000 repeat sampling method. Area under receiver operating characteristic curve (AUC) was used to evaluate the predictive ability of the model.
Looking for future studies?
Notify Me65 year and older
All sexes
Observational
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Data of older patients (age ≥65 years old) undergoing maintenance hemodialysis were collected from 2012-1-December 31, 2014, with data from Beijing Blood Purification Quality Control and Improvement Center (BJHDQCIC).
Beijing Friendship Hospital
Other
A New Risk Score for Predicting 1-year Mortality in Older r Maintenance Hemodialysis Patients.A Cohort Study in Beijing.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03861247
Hyperphosphatemia, Maintenance Hemodialysis
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT07656168
Chronic Disease, Disease Attributes
Beijing, China
View Trial DetailsNCT07522944
Anxiety, Anxiety Disorders
Alexandria, Alexandria Governorate, Egypt
View Trial DetailsNCT07291154
Chronic Disease, Disease Attributes
Chongqing, Chongqing Municipality, China
View Trial Details